CircNova is a biotechnology company that develops therapies within the biotechnology sector
CircNova is a biotechnology company that develops therapies within the biotechnology sector. The company generates, analyzes, and identifies circular ribonucleic acid (RNA) for potential treatments, using artificial intelligence (AI) techniques to predict circular RNA structures. CircNova's technology aims to address clinical needs by targeting diseases that are difficult to treat.